Skip to main content
Katherine (Smith) Clifton, MD, Oncology, Saint Louis, MO

KatherineKeaney(Smith)CliftonMD

Oncology Saint Louis, MO

Breast Cancer

Physician

Dr. Clifton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Clifton's full profile

Already have an account?

  • Office

    4921 Parkview Pl
    # Dv
    Saint Louis, MO 63110
    Phone+1 800-647-2098
    Fax+1 314-362-3192

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2013 - 2016
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 2013

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2021 - 2026
  • MO State Medical License
    MO State Medical License 2019 - 2025
  • TX State Medical License
    TX State Medical License 2016 - 2019
  • MA State Medical License
    MA State Medical License 2013 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Examining progression free survival (PFS), overall survival (OS), and toxicities of palbociclib in a geriatric population. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Pulse – the Link Between Hair Dye and Breast Cancer
    Pulse – the Link Between Hair Dye and Breast CancerDecember 29th, 2019
  • CDK4/6 Inhibitors in Older Breast Cancer Patients: Recent Research Context
    CDK4/6 Inhibitors in Older Breast Cancer Patients: Recent Research ContextNovember 6th, 2019